434 related articles for article (PubMed ID: 16923394)
21. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathways regulating the self-renewal of hematopoietic stem cells.
Stein MI; Zhu J; Emerson SG
Exp Hematol; 2004 Dec; 32(12):1129-36. PubMed ID: 15588937
[TBL] [Abstract][Full Text] [Related]
23. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
Rajasekhar VK; Begemann M
Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
[TBL] [Abstract][Full Text] [Related]
24. A bistable genetic switch which does not require high co-operativity at the promoter: a two-timescale model for the PU.1-GATA-1 interaction.
Bokes P; King JR; Loose M
Math Med Biol; 2009 Jun; 26(2):117-32. PubMed ID: 19181622
[TBL] [Abstract][Full Text] [Related]
25. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
DeKoter RP; Singh H
Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
[TBL] [Abstract][Full Text] [Related]
26. Gfi1 and Gfi1b: key regulators of hematopoiesis.
van der Meer LT; Jansen JH; van der Reijden BA
Leukemia; 2010 Nov; 24(11):1834-43. PubMed ID: 20861919
[TBL] [Abstract][Full Text] [Related]
27. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
Chinen H; Matsuoka K; Sato T; Kamada N; Okamoto S; Hisamatsu T; Kobayashi T; Hasegawa H; Sugita A; Kinjo F; Fujita J; Hibi T
Gastroenterology; 2007 Aug; 133(2):559-73. PubMed ID: 17681176
[TBL] [Abstract][Full Text] [Related]
28. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
29. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
30. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
Walsh JC; DeKoter RP; Lee HJ; Smith ED; Lancki DW; Gurish MF; Friend DS; Stevens RL; Anastasi J; Singh H
Immunity; 2002 Nov; 17(5):665-76. PubMed ID: 12433372
[TBL] [Abstract][Full Text] [Related]
31. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.
Sarrazin S; Mossadegh-Keller N; Fukao T; Aziz A; Mourcin F; Vanhille L; Kelly Modis L; Kastner P; Chan S; Duprez E; Otto C; Sieweke MH
Cell; 2009 Jul; 138(2):300-13. PubMed ID: 19632180
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
[TBL] [Abstract][Full Text] [Related]
33. A panorama of lineage-specific transcription in hematopoiesis.
Kluger Y; Lian Z; Zhang X; Newburger PE; Weissman SM
Bioessays; 2004 Dec; 26(12):1276-87. PubMed ID: 15551261
[TBL] [Abstract][Full Text] [Related]
34. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
[TBL] [Abstract][Full Text] [Related]
35. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.
Nguyen HQ; Hoffman-Liebermann B; Liebermann DA
Cell; 1993 Jan; 72(2):197-209. PubMed ID: 7678779
[TBL] [Abstract][Full Text] [Related]
36. Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate.
Chou ST; Khandros E; Bailey LC; Nichols KE; Vakoc CR; Yao Y; Huang Z; Crispino JD; Hardison RC; Blobel GA; Weiss MJ
Blood; 2009 Jul; 114(5):983-94. PubMed ID: 19491391
[TBL] [Abstract][Full Text] [Related]
37. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates.
Singh H; DeKoter RP; Walsh JC
Cold Spring Harb Symp Quant Biol; 1999; 64():13-20. PubMed ID: 11232277
[No Abstract] [Full Text] [Related]
38. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates.
Spooner CJ; Cheng JX; Pujadas E; Laslo P; Singh H
Immunity; 2009 Oct; 31(4):576-86. PubMed ID: 19818654
[TBL] [Abstract][Full Text] [Related]
39. AML-1 steps up to the platelets.
Irvin BJ; Hiebert SW
Nat Med; 2004 Mar; 10(3):238-9. PubMed ID: 14991045
[No Abstract] [Full Text] [Related]
40. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.
Scott EW; Simon MC; Anastasi J; Singh H
Science; 1994 Sep; 265(5178):1573-7. PubMed ID: 8079170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
